IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.998
AS - Asia 3.070
EU - Europa 3.021
SA - Sud America 808
Continente sconosciuto - Info sul continente non disponibili 325
AF - Africa 149
OC - Oceania 4
AN - Antartide 1
Totale 15.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.784
SG - Singapore 1.175
RU - Federazione Russa 933
CN - Cina 870
IT - Italia 707
BR - Brasile 635
SE - Svezia 399
HK - Hong Kong 334
DE - Germania 221
UA - Ucraina 210
VN - Vietnam 181
FI - Finlandia 170
FR - Francia 137
IN - India 106
GB - Regno Unito 99
CA - Canada 88
BD - Bangladesh 82
CI - Costa d'Avorio 80
AR - Argentina 61
ID - Indonesia 49
IQ - Iraq 36
CO - Colombia 31
MX - Messico 31
TR - Turchia 31
EC - Ecuador 27
SA - Arabia Saudita 26
PK - Pakistan 25
JP - Giappone 24
ZA - Sudafrica 23
VE - Venezuela 22
ES - Italia 20
PH - Filippine 20
BE - Belgio 18
UZ - Uzbekistan 18
IE - Irlanda 17
CW - ???statistics.table.value.countryCode.CW??? 16
NI - Nicaragua 15
CR - Costa Rica 13
JO - Giordania 13
PL - Polonia 13
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 12
SV - El Salvador 11
IL - Israele 10
LT - Lituania 10
NL - Olanda 10
TN - Tunisia 10
CL - Cile 9
GT - Guatemala 9
GP - Guadalupe 8
PE - Perù 8
TT - Trinidad e Tobago 8
BO - Bolivia 7
JM - Giamaica 7
KE - Kenya 7
AZ - Azerbaigian 6
EG - Egitto 6
HN - Honduras 6
NP - Nepal 6
PY - Paraguay 6
SN - Senegal 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
KZ - Kazakistan 5
LB - Libano 5
OM - Oman 5
AL - Albania 4
HR - Croazia 4
MA - Marocco 4
MY - Malesia 4
PR - Porto Rico 4
PT - Portogallo 4
RO - Romania 4
SC - Seychelles 4
AU - Australia 3
GE - Georgia 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
GR - Grecia 2
KG - Kirghizistan 2
KR - Corea 2
QA - Qatar 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
BF - Burkina Faso 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 15.053
Salva come PNG Salva come JPEG
Città #
Ashburn 747
Fairfield 634
Chandler 602
Woodbridge 577
Singapore 572
San Jose 523
Jacksonville 461
Houston 373
Hong Kong 332
Nyköping 327
Seattle 270
Ann Arbor 255
Milan 251
Cambridge 244
Beijing 213
Wilmington 213
Council Bluffs 182
Nanjing 141
Bari 139
New York 137
Lawrence 130
Roxbury 128
Lauterbourg 110
Boardman 99
Rome 91
Dallas 87
Los Angeles 86
Des Moines 84
Abidjan 80
Ho Chi Minh City 72
Helsinki 66
Santa Clara 59
Princeton 58
Inglewood 55
São Paulo 54
Columbus 52
Brooklyn 47
Buffalo 42
Nanchang 42
Hebei 39
Washington 38
Shenyang 33
Jiaxing 32
San Diego 32
Hanoi 30
Dearborn 29
Munich 25
Pune 24
Tokyo 24
Chicago 22
Guangzhou 20
San Francisco 20
Atlanta 19
Phoenix 19
Tianjin 19
Toronto 19
Turin 19
Moscow 18
Baghdad 17
Belo Horizonte 17
Brussels 17
Dublin 17
Jakarta 17
Montreal 17
Shanghai 17
The Dalles 17
Figino 16
Rio de Janeiro 16
Tashkent 16
Willemstad 16
Managua 15
Boston 14
Changsha 14
Amman 13
Brasília 13
Frankfurt am Main 13
Ardabil 12
London 12
Medellín 12
Orem 12
Brno 11
Falkenstein 11
Mumbai 11
Riyadh 11
Salvador 11
Auburn Hills 10
Bologna 10
Chennai 10
Dong Ket 10
Johannesburg 10
Kunming 10
Leawood 10
North Bergen 10
Quito 10
San Salvador 10
Calgary 9
Dhaka 9
Jinan 9
Ningbo 9
San José 9
Totale 9.646
Salva come PNG Salva come JPEG
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 731
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 248
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 209
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 198
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 195
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 190
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 190
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 187
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 174
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 170
Effect of chirality in platinum drugs 169
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 165
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 164
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 163
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 162
Mutagenic activity of some platinum complexes: chemical properties and biological activity 158
Biologic activity of platiunum complexes with proflavine 155
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 147
Endothelial cells in the bone marrow of patients with multiple myeloma 142
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 140
Antitumour platinum iminoether complexes 139
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 136
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 136
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 135
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 135
Antitumour platinum-iminoether complexes 132
Platinum(II) based anticancer agents with a trans geometry 131
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 131
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 130
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 129
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 129
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 129
Antitumour ruthenium(II)-dimethylsulfoxide complexes 129
Antitumour platinum iminoether complexes 128
Antitumor activity of trans platinum complexes 126
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 125
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 124
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 124
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 124
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 123
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 122
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 122
Antitumor active trans-platinum compounds 122
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 121
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 120
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 119
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 117
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 116
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 115
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 111
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 111
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 111
Anttitumor activity of trans-platinum species 110
Current Status of trans-Platinum Compounds in Cancer Therapy 110
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 109
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 106
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 106
Trans-Platinum Complexes in Cancer Therapy 106
In vitro cisplatin effects on phagocyte functions 106
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 105
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 105
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 104
null 104
A trans-platinum complex showing higher antitumor activity than the cis congeners 102
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 101
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 100
Bone Marrow Fibroblasts and Multiple Myeloma Progression 100
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 100
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 100
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 99
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 98
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 97
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 96
Complessi antitumorali di platino a geometria trans 96
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 95
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 93
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 93
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 93
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 92
null 92
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 90
null 88
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 88
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 87
Screening tests for selecting anticancer metal compounds 87
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 86
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 86
Platinum(II) complexes with acyclovir: synthesis and biological activity 84
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 84
Complessi antitumorali di platino a geometria trans 84
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 83
DNA interaction properties of platinum –iminoether complexes 83
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 83
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 82
The IS-BioBank project: a framework for biological data normalization, interoperability, and mining for cancer microenvironment analysis 81
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 81
Mutagenic activity of some paltinum complexes: Chemical properties and biological activity 81
Synthesis, crystal structure, spectral properties and in vitro antitumor activity of platinum(II) complexes of 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones 80
Complessi antimetastatici di rutenio 80
A new generation of platinum anticancer complexes with trans geometry 80
Totale 12.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022614 0 0 0 0 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/20251.919 138 30 183 64 46 132 206 137 54 94 294 541
2025/20264.851 564 172 335 486 490 229 434 105 1.105 350 111 470
2026/20271.204 105 221 351 510 17 0 0 0 0 0 0 0
Totale 15.376